Aspire Biopharma Holdings, Inc. (ASBP)
4.94
-0.36
(-6.79%)
USD |
NASDAQ |
May 14, 09:55
Aspire Biopharma Holdings EPS Diluted (Quarterly) : -39.97 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Veru, Inc. | 0.00 |
| IGC Pharma, Inc. | -0.0076 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.708M |
| Revenue (Quarterly) | 0.0043M |
| Total Expenses (Quarterly) | 4.712M |
| Enterprise Value | 10.59M |
| Gross Profit Margin (Quarterly) | -23.26% |
| Profit Margin (Quarterly) | -109.5K% |
| Earnings Yield | -2.70K% |
| Normalized Earnings Yield | -3147.71 |